Airgain filings document regulatory disclosures for a Nasdaq-listed wireless connectivity company, including Form 8-K reports on operating results and material events, proxy materials, and exhibits tied to press releases and compensation matters.
The filing record addresses financial condition, corporate governance, executive compensation, equity award practices, officer changes, capital-structure disclosures, and reporting obligations associated with Airgain’s common stock and connectivity portfolio. Proxy filings include shareholder voting and pay-versus-performance information, while current reports record quarterly and annual results announcements and governance changes.
Airgain President and CEO Jacob Suen reported open-market sales of the company’s common stock. On February 9, 2026, he sold 6,112 shares at a weighted average price of $5.0068 per share. On February 10, 2026, he sold another 888 shares at a weighted average price of $5.0745 per share.
The transactions were carried out under a pre-arranged Rule 10b5-1 trading plan established on March 12, 2025. Following these sales, Suen directly owned 286,635 shares of Airgain common stock, which the filing notes include restricted stock units.
Airgain, Inc. Chief Technology Officer Sadri Ali reported small stock sales under a pre-set trading plan. On February 9, he sold 2,119 shares of common stock at a weighted average price of $5.0095 per share. On February 10, he sold 881 shares at a weighted average price of $5.2426 per share.
The filing notes these open-market sales were executed pursuant to a Rule 10b5-1 trading plan established on August 13, 2025. After the transactions, Ali directly beneficially owned 124,030 shares of Airgain common stock, a figure that includes restricted stock units.
Airgain insider Ali S. Sadri has filed to sell common stock under Rule 144. The notice covers 881 shares of Airgain common stock to be sold through Fidelity Brokerage Services on NASDAQ, with an aggregate market value of $4,618.71 and an approximate sale date of February 10, 2026.
The shares were acquired through restricted stock vesting from the issuer, including 199 shares on March 1, 2024 and 682 shares on May 15, 2025 as compensation. Over the prior three months, Ali S. Sadri sold 2,119 Airgain common shares for gross proceeds of $10,615.13.
Airgain Inc. filed a Form 144 notice for a planned stock sale. The person for whose account the sale will occur plans to sell 2,119 shares of common stock through Fidelity Brokerage Services LLC on or about 02/09/2026 on NASDAQ, with an aggregate market value of $10,615.13 and 11,958,193 shares of common stock outstanding.
The shares to be sold were acquired from the issuer through restricted stock vesting as compensation, including 1,524 shares on 03/01/2024 and 595 shares on 05/15/2025.
An AIRG shareholder, Jacob Suen, filed a Rule 144 notice to sell 7,000 shares of common stock through Morgan Stanley Smith Barney on or about February 9, 2026 on NASDAQ. These shares came from restricted stock units acquired from the issuer on March 1, 2020.
The notice also lists Suen’s sales of 15,993 common shares for gross proceeds of $63,908.03 on January 20, 2026 and 2,070 shares for $8,258.27 on November 24, 2025. Common shares outstanding were 11,958,193 at the time of the planned sale.
Airgain, Inc. director Arthur M. Toscanini reported equity awards in the form of restricted stock units (RSUs) and stock options. He acquired 7,257 shares of common stock on February 2, 2026, representing RSUs that each convert into one share, at a grant price of $0. Following this, he beneficially owned 112,992 shares of common stock, including RSUs. He was also granted a stock option for 12,660 shares at an exercise price of $4.27 per share, with all option shares and RSUs scheduled to vest 100% on February 2, 2027, subject to his continued service. The option expires on February 1, 2036, and all reported holdings are listed as directly owned.
Airgain, Inc. director James K. Sims received new equity awards. On February 2, 2026, he was granted 10,885 restricted stock units with a grant price of $0. All of these RSUs vest on February 2, 2027, if he continues serving the company through that date.
He also received a stock option for 18,991 shares at an exercise price of $4.27 per share, vesting 100% on February 2, 2027 and expiring on February 1, 2036. After these awards, he directly holds 433,223 shares of common stock, which includes RSUs, and 18,991 stock options.
Airgain, Inc. director Thomas A. Munro received new equity awards in the form of restricted stock units and stock options. On February 2, 2026, he was granted 7,257 shares of common stock as RSUs at a price of $0, bringing his directly held and RSU-included common stock holdings to 84,171 shares. He was also granted a stock option covering 12,660 shares at an exercise price of $4.27 per share, vesting 100% on February 2, 2027 and expiring on February 1, 2036, contingent on continued service.
Airgain, Inc. director Joan H. Gillman received new equity awards as part of her compensation. On February 2, 2026, she was granted 7,257 shares of common stock in the form of restricted stock units at no cost, which all vest on February 2, 2027 if she continues serving the company.
She also received a stock option covering 12,660 shares of common stock with an exercise price of $4.27 per share, vesting 100% on February 2, 2027 and expiring on February 1, 2036. After these grants, she beneficially owns 43,991 shares of Airgain common stock, including RSUs, held directly.
Airgain, Inc. director T J Chung received new equity awards in the form of restricted stock units and stock options. On February 2, 2026, Chung was granted 7,257 RSUs at a price of $0, which fully vest on February 2, 2027, if service continues. On the same date, Chung received a stock option for 12,660 shares at an exercise price of $4.27 per share, vesting 100% on February 2, 2027 and expiring on February 1, 2036. Following these grants, Chung directly beneficially owned 51,015 shares of common stock, including RSUs, and 12,660 stock options.